Platelet Dopamine Uptake in Huntington's Chorea and Gilles de la Tourette's Syndrome: Effect of Haloperidol

11Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Uptake of 14C-dopamine by human platelets has been studied in two diseases, namely Gilles de la Tourette's syndrome and Huntington's chorea, in which abnormal metabolism of dopamine has been implicated. Platelets from untreated Huntington's chorea patients showed a small increase in Km and Vmax.; platelets from patients in all other groups showed an uptake identical with the controls. Haloperidol (10 -5M) was also shown to be a strong non-competitive inhibitor of 14C-DA uptake by platelets. This property is probably unrelated to the drugs' action in ameliorating the symptoms of Huntington's chorea which is likely related to the increase in cholinergic neuronal activity produced by neuroleptic blockade of dopamine receptors. © 1977, Canadian Neurological Sciences Federation. All rights reserved.

Cite

CITATION STYLE

APA

Butterworth, R. F., Gonce, M., & Barbeau, A. (1977). Platelet Dopamine Uptake in Huntington’s Chorea and Gilles de la Tourette’s Syndrome: Effect of Haloperidol. Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques, 4(4), 285–288. https://doi.org/10.1017/S0317167100025130

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free